echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Clin Trans Gastro: Absorbable gelatin sponge embolism under endoscopy ultrasound is superior to traditional cyanide injections to treat gastric veins

    Clin Trans Gastro: Absorbable gelatin sponge embolism under endoscopy ultrasound is superior to traditional cyanide injections to treat gastric veins

    • Last Update: 2020-07-10
    • Source: Internet
    • Author: User
    Tags

    what re

    all

    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Introduction:gastric varicose (GV) bleeding is a complication of cirrhosisTraditional endoscopy therapy for cyanide (CYA) injections can be challenging, while endoscopic ultrasound (EUS)-guided hemostatic coils have shown high treatment success ratesThe purpose of this study was to compare the differences in the clinical results of EUS-guided coil embolism with endoscopy CYA injection treatment GVhow to:The researchers conducted a matching cohort study using a forward-looking registry involving two three-level centersA total of 10 patients treated with EUS-based coils matched 30 patients receiving CYA injections in a 1:3 mannerMatching criteria include GV type, Charlson comorbidity index, and bleeding severityThe main result is technical success and complicationsThe secondary result was rebleeding rate, re-intervention rate, total blood transfusion needs and time-of-event analysis (re-bleeding, re-intervention and blood transfusion)Result:The technical success rate of EUS coil therapy is 100%, while the technology success rate of CYA injection is 96.7% (P - 1.0)The incidence of complications in the EUS coil group was 10%, while the CYA group was 20% (P - 0.65)At 9 months, EUS coil patients did not bleed again, compared with 38% in the CYA groupPatients without EUS coils need blood transfusions to treat GV rebleeding, while more than 50% of CYA patients require blood transfusions Ten per cent of EUS coil patients need to intervene again, compared with 60 per cent of CYA patients Re-intervention time of the EUS coil group, GV rebleeding time and blood transfusion time are longer (all P 05) discussion: The EUS-guided coil injection appears to be superior to GV treatment compared to CYA
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.